Enomoto Clinic

Kumagaya 360-0018

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis, Eczema

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling